BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24891465)

  • 1. Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti.
    Carter TE; Maloy H; von Fricken M; St Victor Y; Romain JR; Okech BA; Mulligan CJ
    Am J Trop Med Hyg; 2014 Aug; 91(2):412-4. PubMed ID: 24891465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
    Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-6-phosphate Dehydrogenase (G6PD) A-Variant Frequency and Novel Polymorphism in Haiti.
    Vincent JP; Existe AV; Komaki-Yasuda K; Boncy J; Kano S
    Am J Trop Med Hyg; 2022 Nov; 107(5):1142-1144. PubMed ID: 36191877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
    Howes RE; Piel FB; Patil AP; Nyangiri OA; Gething PW; Dewi M; Hogg MM; Battle KE; Padilla CD; Baird JK; Hay SI
    PLoS Med; 2012; 9(11):e1001339. PubMed ID: 23152723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
    White NJ; Qiao LG; Qi G; Luzzatto L
    Malar J; 2012 Dec; 11():418. PubMed ID: 23237606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
    Dysoley L; Kim S; Lopes S; Khim N; Bjorges S; Top S; Huch C; Rekol H; Westercamp N; Fukuda MM; Hwang J; Roca-Feltrer A; Mukaka M; Menard D; Taylor WR
    BMC Infect Dis; 2019 Mar; 19(1):250. PubMed ID: 30871496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
    Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
    Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
    Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
    BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.
    Carter N; Pamba A; Duparc S; Waitumbi JN
    Malar J; 2011 Aug; 10():241. PubMed ID: 21849081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
    Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling primaquine-induced haemolysis in G6PD deficiency.
    Watson J; Taylor WR; Menard D; Kheng S; White NJ
    Elife; 2017 Feb; 6():. PubMed ID: 28155819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
    Bastiaens GJH; Tiono AB; Okebe J; Pett HE; Coulibaly SA; Gonçalves BP; Affara M; Ouédraogo A; Bougouma EC; Sanou GS; Nébié I; Bradley J; Lanke KHW; Niemi M; Sirima SB; d'Alessandro U; Bousema T; Drakeley C
    PLoS One; 2018; 13(1):e0190272. PubMed ID: 29324864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-6-phosphate dehydrogenase deficiency genotypes and allele frequencies in the Kavango and Zambezi regions of northern Namibia.
    Haiyambo DH; Ilunga A; Nangombe R; Ababio G; Hatuikulipi T; Aleksenko L; Misihairabgwi J; Uusiku P; Pernica JM; Greco B; Quaye IK
    Trans R Soc Trop Med Hyg; 2019 Aug; 113(8):483-488. PubMed ID: 31086985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
    Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
    Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study.
    Assefa A; Ali A; Deressa W; Tsegaye W; Abebe G; Sime H; Kebede A; Jima D; Kassa M; Abreha T; Teka H; Solomon H; Malone J; Shi YP; Zhou Z; Reithinger R; Hwang J
    Malar J; 2018 Oct; 17(1):388. PubMed ID: 30367627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.
    Ali Albsheer MM; Lover AA; Eltom SB; Omereltinai L; Mohamed N; Muneer MS; Mohamad AO; Abdel Hamid MM
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009720. PubMed ID: 34699526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
    Eziefula AC; Pett H; Grignard L; Opus S; Kiggundu M; Kamya MR; Yeung S; Staedke SG; Bousema T; Drakeley C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4971-3. PubMed ID: 24913169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.